| Heading: |
Epilepsy: Drugs |
| Question ID: |
1804968 |
| UIN: |
53929 |
| House: |
Commons |
| Date tabled: |
2025-05-21 |
| Asking Member ID: |
4519 |
| Asking Member display name: |
James Cartlidge
|
| Asking Member handle: |
jcartlidgemp
|
| Asking Member Twitter reference: |
@jcartlidgemp
|
| Member interest: |
false |
| Question text: |
To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the adequacy of the availability of epilepsy drugs. |
| Is named day: |
false |
| Date of holding answer: |
|
| Date answered: |
2025-06-02 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
4444 |
| Answering Member display name: |
Karin Smyth
|
| Answering Member handle: |
karinsmyth
|
| Answering Member Twitter reference: |
@karinsmyth
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
The Department is working hard with industry to help resolve intermittent supply issues with some epilepsy medications. As a result of ongoing activity and intensive work, including directing suppliers to expedite deliveries, most issues have been resolve... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |